Nobilis Health (HLTH) was Upgraded to a Buy Rating at Benchmark Co.


In a report released today, Bill Sutherland from Benchmark Co. upgraded Nobilis Health (HLTH) to Buy. The company’s shares closed yesterday at $0.44.

According to TipRanks.com, Sutherland is ranked #1962 out of 5110 analysts.

The the analyst consensus on Nobilis Health is currently a Hold rating.

See today’s analyst top recommended stocks >>

Based on Nobilis Health’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $885K. In comparison, last year the company had a net profit of $3.6 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Nobilis Health Corp. engages in the operation and development of outpatient surgery centers. The firm owns and manages ambulatory and acute care facilities to deliver innovative surgical services. It operates through Medical Services and Marketing Services segment.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts